NRX Stock Based Compensation vs Change In Cash Analysis

NRXP Stock  USD 2.29  0.14  5.76%   
NRX Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating NRX Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NRX Pharmaceuticals is a good investment. Please check the relationship between NRX Pharmaceuticals Stock Based Compensation and its Change In Cash accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRX Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.

Stock Based Compensation vs Change In Cash

Stock Based Compensation vs Change In Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NRX Pharmaceuticals Stock Based Compensation account and Change In Cash. At this time, the significance of the direction appears to have strong relationship.
The correlation between NRX Pharmaceuticals' Stock Based Compensation and Change In Cash is 0.6. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of Change In Cash in the same time period over historical financial statements of NRX Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of NRX Pharmaceuticals' Stock Based Compensation and Change In Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of NRX Pharmaceuticals are associated (or correlated) with its Change In Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change In Cash has no effect on the direction of Stock Based Compensation i.e., NRX Pharmaceuticals' Stock Based Compensation and Change In Cash go up and down completely randomly.

Correlation Coefficient

0.6
Relationship DirectionPositive 
Relationship StrengthSignificant

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Change In Cash

Most indicators from NRX Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NRX Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRX Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.At this time, NRX Pharmaceuticals' Selling General Administrative is relatively stable compared to the past year. As of 02/27/2025, Issuance Of Capital Stock is likely to grow to about 19.7 M, while Enterprise Value Over EBITDA is likely to drop (1.24).
 2022 2023 2024 2025 (projected)
Total Operating Expenses44.4M27.6M31.7M32.9M
Cost Of Revenue4K5K4.5K4.3K

NRX Pharmaceuticals fundamental ratios Correlations

-0.63-0.840.980.00.85-0.91-0.440.97-0.67-0.440.97-0.470.970.92-0.47-0.82-0.85-0.480.97-0.74-0.950.0-0.080.820.74
-0.630.92-0.75-0.08-0.330.470.16-0.580.120.16-0.570.47-0.58-0.590.10.220.910.17-0.570.110.53-0.03-0.6-0.55-0.14
-0.840.92-0.92-0.05-0.650.720.31-0.80.390.31-0.790.55-0.8-0.840.330.541.00.35-0.790.440.79-0.07-0.33-0.78-0.46
0.98-0.75-0.920.020.81-0.88-0.420.95-0.59-0.420.95-0.520.950.92-0.45-0.75-0.93-0.460.95-0.66-0.920.010.050.830.67
0.0-0.08-0.050.020.19-0.05-0.820.240.34-0.820.23-0.70.230.28-0.5-0.16-0.05-0.790.230.21-0.24-0.92-0.35-0.350.29
0.85-0.33-0.650.810.19-0.92-0.680.91-0.72-0.680.9-0.580.910.93-0.72-0.98-0.65-0.720.9-0.86-0.9-0.08-0.480.750.97
-0.910.470.72-0.88-0.05-0.920.51-0.90.790.51-0.90.37-0.9-0.890.450.920.720.54-0.90.780.88-0.040.33-0.74-0.87
-0.440.160.31-0.42-0.82-0.680.51-0.650.141.0-0.640.84-0.65-0.670.840.670.321.0-0.640.380.640.730.58-0.15-0.76
0.97-0.58-0.80.950.240.91-0.9-0.65-0.59-0.651.0-0.651.00.97-0.64-0.88-0.82-0.691.0-0.72-0.98-0.21-0.230.740.84
-0.670.120.39-0.590.34-0.720.790.14-0.590.14-0.58-0.07-0.59-0.560.190.770.380.17-0.580.790.57-0.40.38-0.68-0.69
-0.440.160.31-0.42-0.82-0.680.511.0-0.650.14-0.640.84-0.65-0.670.840.670.321.0-0.640.380.640.730.58-0.15-0.76
0.97-0.57-0.790.950.230.9-0.9-0.641.0-0.58-0.64-0.641.00.96-0.63-0.87-0.81-0.681.0-0.72-0.98-0.22-0.220.730.83
-0.470.470.55-0.52-0.7-0.580.370.84-0.65-0.070.84-0.64-0.64-0.690.860.490.570.86-0.640.320.640.580.14-0.35-0.55
0.97-0.58-0.80.950.230.91-0.9-0.651.0-0.59-0.651.0-0.640.97-0.64-0.87-0.81-0.681.0-0.72-0.98-0.21-0.230.730.83
0.92-0.59-0.840.920.280.93-0.89-0.670.97-0.56-0.670.96-0.690.97-0.66-0.86-0.84-0.70.96-0.7-0.98-0.19-0.220.740.84
-0.470.10.33-0.45-0.5-0.720.450.84-0.640.190.84-0.630.86-0.64-0.660.70.350.86-0.630.640.640.420.5-0.45-0.76
-0.820.220.54-0.75-0.16-0.980.920.67-0.880.770.67-0.870.49-0.87-0.860.70.540.7-0.870.90.860.070.58-0.7-0.98
-0.850.911.0-0.93-0.05-0.650.720.32-0.820.380.32-0.810.57-0.81-0.840.350.540.36-0.810.460.8-0.06-0.33-0.78-0.47
-0.480.170.35-0.46-0.79-0.720.541.0-0.690.171.0-0.680.86-0.68-0.70.860.70.36-0.680.430.680.690.58-0.21-0.79
0.97-0.57-0.790.950.230.9-0.9-0.641.0-0.58-0.641.0-0.641.00.96-0.63-0.87-0.81-0.68-0.72-0.98-0.22-0.220.730.83
-0.740.110.44-0.660.21-0.860.780.38-0.720.790.38-0.720.32-0.72-0.70.640.90.460.43-0.720.71-0.260.45-0.84-0.84
-0.950.530.79-0.92-0.24-0.90.880.64-0.980.570.64-0.980.64-0.98-0.980.640.860.80.68-0.980.710.230.25-0.71-0.83
0.0-0.03-0.070.01-0.92-0.08-0.040.73-0.21-0.40.73-0.220.58-0.21-0.190.420.07-0.060.69-0.22-0.260.230.350.45-0.2
-0.08-0.6-0.330.05-0.35-0.480.330.58-0.230.380.58-0.220.14-0.23-0.220.50.58-0.330.58-0.220.450.250.350.08-0.67
0.82-0.55-0.780.83-0.350.75-0.74-0.150.74-0.68-0.150.73-0.350.730.74-0.45-0.7-0.78-0.210.73-0.84-0.710.450.080.6
0.74-0.14-0.460.670.290.97-0.87-0.760.84-0.69-0.760.83-0.550.830.84-0.76-0.98-0.47-0.790.83-0.84-0.83-0.2-0.670.6
Click cells to compare fundamentals

NRX Pharmaceuticals Account Relationship Matchups

NRX Pharmaceuticals fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets2.9M32.7M25.8M7.3M6.6M6.3M
Other Current Liab42.7M7.7M5.8M5.3M6.0M9.7M
Total Current Liabilities46.2M11.9M16.6M19.0M21.9M14.9M
Total Stockholder Equity(43.8M)20.8M7.4M(11.7M)(10.6M)(10.0M)
Net Debt(1.1M)(27.1M)(9.5M)4.6M4.1M4.3M
Retained Earnings(90.2M)(183.2M)(223.1M)(253.1M)(227.8M)(216.4M)
Accounts Payable3.2M3.7M2.1M4.6M5.3M5.6M
Cash1.9M27.6M20.1M4.6M5.3M8.6M
Non Current Assets Total11K15K21K431K387.9K368.5K
Non Currrent Assets Other11K15K21K431K495.7K520.4K
Cash And Short Term Investments1.9M27.6M20.1M4.6M5.3M8.6M
Common Stock Shares Outstanding34.3M46.9M65.8M7.6M8.7M8.3M
Liabilities And Stockholders Equity2.9M32.7M25.8M7.3M6.6M6.3M
Other Current Assets240K5.1M11.5M2.3M2.6M3.0M
Other Stockholder Equity46.4M204.0M230.3M241.3M277.5M291.4M
Total Liab46.7M11.9M18.4M19.0M21.9M15.7M
Total Current Assets2.9M32.7M25.8M6.9M7.9M10.8M
Common Stock43K59K67K84K75.6K71.8K
Short Long Term Debt Total797K518K10.5M9.2M10.5M11.1M

Additional Tools for NRX Stock Analysis

When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.